reboxetine has been researched along with maprotiline in 3 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (maprotiline) | Trials (maprotiline) | Recent Studies (post-2010) (maprotiline) |
---|---|---|---|---|---|
626 | 193 | 184 | 933 | 211 | 59 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertolín-Guillén, JM; Climent-Díaz, B; Navarré-Gimeno, A | 1 |
Benveniste, H; Carter, P; Ding, YS; Lin, KS; Logan, J | 1 |
Li, B; Li, X; Li, Y; Wang, P; Xue, W; Yang, F; Yao, X; Zheng, G; Zhu, F | 1 |
3 other study(ies) available for reboxetine and maprotiline
Article | Year |
---|---|
Serotonin syndrome due to association of venlafaxine, maprotiline and reboxetine.
Topics: Cyclohexanols; Depressive Disorder; Emergency Medical Services; Humans; Male; Maprotiline; Middle Aged; Morpholines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 2004 |
Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisox
Topics: Adrenergic Uptake Inhibitors; Animals; Autoradiography; Benzopyrans; Binding, Competitive; Brain; Brain Chemistry; Brain Mapping; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluoxetine; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Maprotiline; Mice; Morpholines; Nordefrin; Norepinephrine Plasma Membrane Transport Proteins; Papio; Positron-Emission Tomography; Protein Binding; Radioligand Assay; Reboxetine; Symporters; Time Factors; Tissue Distribution | 2005 |
Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study.
Topics: Amino Acid Motifs; Antipsychotic Agents; Atomoxetine Hydrochloride; Binding Sites; Humans; Maprotiline; Molecular Docking Simulation; Molecular Dynamics Simulation; Morpholines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Reboxetine; Stereoisomerism; Structural Homology, Protein; Thermodynamics; Viloxazine | 2016 |